Zensita MP Tablet SR contains a combination of Metformin 500mg, Pioglitazone 15mg and Sitagliptin 100mg in sustained-release tablet form. It belongs to the ANTI DIABETIC category and is manufactured and marketed by Zuventus Healthcare Ltd.
Composition
- Metformin: 500mg
- Pioglitazone: 15mg
- Sitagliptin: 100mg
Product Information
- Product Name: Zensita MP Tablet SR
- Generic: Metformin 500mg + Pioglitazone 15mg + Sitagliptin 100mg
- Dosage Form: Sustained-Release Tablet
- Manufacturer: Zuventus Healthcare Ltd
- Marketer: Zuventus Healthcare Ltd
- Category: ANTI DIABETIC
About Metformin, Pioglitazone and Sitagliptin
Metformin is an oral antidiabetic medicine that helps reduce blood glucose levels, primarily by decreasing glucose production in the liver and improving insulin sensitivity.
Pioglitazone is a thiazolidinedione antidiabetic medicine that improves insulin sensitivity and helps the body use insulin more effectively.
Sitagliptin is a DPP-4 inhibitor that helps increase insulin release in response to meals and reduce the production of glucose by the liver.
Usage Information
Use Zensita MP Tablet SR only as directed by your doctor or healthcare professional. Swallow the sustained-release tablet as instructed and follow the prescribed dosage and schedule.
For complete product information, including dosage, storage instructions, precautions, contraindications, and expiry details, refer to the original packaging before use.
